Olema Pharmaceuticals, Inc. OLMA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s return on equity?
- Olema Pharmaceuticals, Inc. (OLMA) reported return on equity of -42.9% in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s return on equity changed year-over-year?
- Olema Pharmaceuticals, Inc.'s return on equity decreased by 3.1% year-over-year, from -41.6% to -42.9%.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s return on equity?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s return on equity has grown at a 12.5% compound annual growth rate (CAGR), from -22.8% to -36.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.